Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Enzyme Involved In Inflammatory Bowel Disease Discovered At Penn State College Of Medicine
Researchers at Penn State College of Medicine, working with biochemists, geneticists and clinicians at the University of Bern, Switzerland and in the United Kingdom, have discovered an enzyme that has a key role in inflammatory bowel disease (IBD). The team, co-led by Judith Bond, Ph.D., Distinguished Professor and Chair of Biochemistry and Molecular Biology at Penn State College of Medicine, and Daniel Lottaz, Department of Rheumatology and Clinical Immunology at the University of Bern, Switzerland, could potentially lead to therapies to help the half-a-million Americans affected by ulcerative colitis and Crohn"s disease, collectively referred to as IBD.
generic viagra online
Chemists Explain The Switchboards In Our Cells
Our cells are controlled by billions of molecular "switches" and chemists at UC Santa Barbara have developed a theory that explains how these molecules work. Their findings may significantly help efforts to build biologically based sensors for the detection of chemicals ranging from drugs to explosives to disease markers.
News of the day
Technology Discovered At University of Virginia Now Helps Men To Monitor Their Fertility After Vasectomy
A new home test kit called SpermCheck Vasectomy, based on a protein discovered at the University of Virginia (UVA) Health System, marks the launch of a product line that could revolutionize the way men monitor their reproductive status. Based on antibodies that bind to SP-10, a protein discovered in the laboratory of John C. Herr, PhD, SpermCheck Vasectomy is the only FDA-approved immunodiagnostic test for monitoring sperm after vasectomy.
Endocrinology

American Society Of Hematology Awards Grants To Encourage Novel Medical Training Programs

The American Society of Hematology (ASH) announces that Ellis J. Neufeld, MD, PhD, of Harvard Medical School, Thomas Shea, MD, of University of North Carolina at Chapel Hill, and Alvin Schmaier, MD, of Case Western Reserve University in Cleveland, will each receive ASH"s Alternative Training Pathway Grant this July. The grant is awarded to selected training program directors to encourage the development and implementation of novel hematology-related training programs in recognition of the need for more clinicians and clinical/translational researchers in hematology-related disciplines. "This program encourages creative approaches to meeting the demands of a growing number of trainees who are expressing interest in pursuing hybrid careers" said ASH President Nancy Berliner, MD, Chief of Hematology at Brigham and Women"s Hospital in Boston, and Professor of Medicine at Harvard Medical School. "We hope to expand the opportunities available to clinician-scientists interested in hematology-related careers by allowing hematology training to be enhanced and expanded by combining it with other specialties such as pathology, lab medicine, and transfusion medicine, as well as providing for combined pediatric and adult hematology training." Each recipient"s curriculum will integrate new advances and technologies into traditional hematology training programs. Specifically, Dr. Neufeld"s grant will support training for residents in both pediatric and adult hematology, Dr. Shea"s grant will support training in transitional care for adolescent and young adult survivors of childhood cancer and blood diseases, and Dr. Schmaier will receive a grant to support specialized clinical and basic research training in benign hematology. The Alternative Training Pathway Grant is awarded over a one- to two-year period and is offered to training program directors in hematology, hematology/medical oncology, and other hematology-related disciplines in the United States, Canada, and Mexico. The American Society of Hematology is the world"s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ASH launched Blood: The Vital Connection , a credible online re addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options. American Society of Hematology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009